CUSIP: 61240F108
What is CUSIP 61240F108?
CUSIP 61240F108 identifies MTRY - MONTEREY BIO ACQUISITION COR - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 61240F108:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q4 | 0 | $0 | -$14,443,024 | 0 | |
| 2023 Q3 | 1,287,844 | $14,443,024 | -$673,161 | $11.16 | 15 |
| 2023 Q2 | 1,352,101 | $14,735,638 | -$4,984,498 | $10.92 | 15 |
| 2023 Q1 | 1,822,260 | $19,461,647 | -$59,103 | $10.68 | 13 |
| 2022 Q4 | 1,829,169 | $19,176,146 | -$69,314,764 | $10.50 | 16 |
| 2022 Q3 | 8,544,230 | $87,454,463 | -$26,786,238 | $10.12 | 34 |
| 2022 Q2 | 11,347,076 | $113,637,000 | +$3,311,801 | $10.02 | 44 |
| 2022 Q1 | 11,017,417 | $109,735,000 | +$12,473,224 | $9.96 | 41 |
| 2021 Q4 | 9,766,824 | $96,403,600 | +$94,218,600 | $9.87 | 34 |